February 11, 2015
Cortendo Completes $26.4M in Private Placement from Leading U.S. and EU Investors
Media
February 10, 2015
Ultragenyx Announces Positive 36-Week Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7
February 09, 2015
CERENIS THERAPEUTICS announces the appointment of a new Chief Medical Officer and new Board Members
February 07, 2015
Q4 2014 General Market Overview
February 06, 2015
Orexo commences patent infringement litigation against Actavis concerning Abstral® in the US
February 04, 2015
BeneChill, Inc. Announces Positive Results from COOLHEAD Clinical Study
February 02, 2015
Cortendo to Present at the 17th Annual BIO CEO & Investor Conference
February 02, 2015
Preliminary result of Aerocrine’s rights issue
January 30, 2015
Aerocrine AB Receives Japanese Health Authority Clearance For NIOX VERO®
January 29, 2015
COR-003 Phase 3 Study Protocol to be Presented at ENDO 2015: The Endocrine Society’s 97th Annual Meeting & Expo